Cargando…

Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib

Detalles Bibliográficos
Autores principales: Telang, Sucheta, O’Neal, Julie, Tapolsky, Gilles, Clem, Brian, Kerr, Alan, Imbert-Ferndandez, Yoannis, Chesney, Jason
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072985/
http://dx.doi.org/10.1186/2049-3002-2-S1-P14
_version_ 1782323048713551872
author Telang, Sucheta
O’Neal, Julie
Tapolsky, Gilles
Clem, Brian
Kerr, Alan
Imbert-Ferndandez, Yoannis
Chesney, Jason
author_facet Telang, Sucheta
O’Neal, Julie
Tapolsky, Gilles
Clem, Brian
Kerr, Alan
Imbert-Ferndandez, Yoannis
Chesney, Jason
author_sort Telang, Sucheta
collection PubMed
description
format Online
Article
Text
id pubmed-4072985
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40729852014-07-01 Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib Telang, Sucheta O’Neal, Julie Tapolsky, Gilles Clem, Brian Kerr, Alan Imbert-Ferndandez, Yoannis Chesney, Jason Cancer Metab Poster Presentation BioMed Central 2014-05-28 /pmc/articles/PMC4072985/ http://dx.doi.org/10.1186/2049-3002-2-S1-P14 Text en Copyright © 2014 Telang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Telang, Sucheta
O’Neal, Julie
Tapolsky, Gilles
Clem, Brian
Kerr, Alan
Imbert-Ferndandez, Yoannis
Chesney, Jason
Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title_full Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title_fullStr Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title_full_unstemmed Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title_short Discovery of a PFKFB3 inhibitor for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib
title_sort discovery of a pfkfb3 inhibitor for phase i trial testing that synergizes with the b-raf inhibitor vemurafenib
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072985/
http://dx.doi.org/10.1186/2049-3002-2-S1-P14
work_keys_str_mv AT telangsucheta discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT onealjulie discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT tapolskygilles discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT clembrian discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT kerralan discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT imbertferndandezyoannis discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib
AT chesneyjason discoveryofapfkfb3inhibitorforphaseitrialtestingthatsynergizeswiththebrafinhibitorvemurafenib